Combination therapy in dyslipidaemia – A practical approach

Image for home page

Professor Frederick Raal and Dr Zaheer Bayat consider a practical approach to optimal lipid-lowering therapy for patients who are at high or very high risk of atherosclerotic cardiovascular disease (ASCVD)

Learning objectives

  • How to assess cardiovascular risk and determine the low-density lipoprotein cholesterol (LDL-c) treatment goal for each patient based on their risk
  • To understand the safety and efficacy of different pharmacological lipid-lowering therapies, how to sequence these treatments, and the benefits of an early and aggressive lipid-lowering strategy
  • The benefits of combination statin-ezetimibe therapy, particularly as first-line treatment for patients at high or very high cardiovascular risk.

To access this module, please register or login: